Concepedia

Marcus Saarinen

MS

Statistics

Publications

5

Citations

163

H-Index

5

Active since

2018

Affiliations

Karolinska Institutet(Current)

Science for Life Laboratory

King's College London

Umeå University

Uppsala University

Marcus Saarinen is an author at Karolinska Institutet specializing in medicinal chemistry, alpha-adrenergic pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

2018–2024

5

Publications

5

Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson’s Disease

Mariama Jaiteh, Alexey A. Zeifman, Marcus Saarinen et al. · Journal of Medicinal Chemistry · 2018 · 55 citations · Full text

AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1

Alejandro Díaz‐Holguín, Marcus Saarinen, Duc Duy Vo et al. · Science Advances · 2024 · 42 citations · Full text

, , +19

TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP-363856

Marcus Saarinen, Ioannis Mantas, Ivana Flais et al. · Neuropsychopharmacology · 2022 · 32 citations · Full text

In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics

Richard Ågren, Nibal Betari, Marcus Saarinen et al. · The International Journal of Neuropsychopharmacology · 2023 · 19 citations · Full text

Claustrum and dorsal endopiriform cortex complex cell-identity is determined by Nurr1 and regulates hallucinogenic-like states in mice

Ioannis Mantas, Ivana Flais, Yuvarani Masarapu et al. · Nature Communications · 2024 · 15 citations · Full text

1–5 of 5